PDMR
|
ADSs acquired under the Alexion equity awards
|
Ordinary Shares acquired under restricted share award
|
Aradhana Sarin
|
29,362
|
7,514
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Aradhana Sarin
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Financial Officer
| |
b)
|
Initial notification/Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
AstraZeneca PLC American Depositary Shares
CUSIP: 046353108
| |
b)
|
Nature of the transaction
|
Acquisition of AstraZeneca PLC American Depository Shares pursuant to a vesting under the Global Restricted Stock Plan
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
0
|
29,362
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
9 February 2023
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Aradhana Sarin
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Financial Officer
| |
b)
|
Initial notification/Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
| |
b)
|
Nature of the transaction
|
Acquisition of AstraZeneca PLC Ordinary Shares pursuant to a vesting of a Restricted Share Award
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
0
|
7,514
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
9 February 2023
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AstraZeneca plc published this content on 13 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 February 2023 14:17:03 UTC.